RE: Vela5 Dec 2020 20:59
It is competition if it’s marketed as such...excerpt from the article “ exploring whether use of metformin before admission to hospital for COVID-19 (based on filled pharmacy prescriptions of at least 90 days within 12 months of COVID-19 diagnosis) could affect in-hospital mortality of people with type 2 diabetes and obesity and, if so, the extent of this effect. According to Bramante and colleagues' analysis, metformin was associated with a significant reduction in the risk of mortality in women, but not in men.”